Aclarion (ACONW) Competitors $0.02 0.00 (-1.19%) (As of 12/20/2024 05:15 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends ACONW vs. AONC, DHACW, CORBF, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, and FMSShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include American Oncology Network (AONC), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Fresenius Medical Care (FMS). These companies are all part of the "healthcare" industry. Aclarion vs. American Oncology Network Digital Health Acquisition Global Cord Blood LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care American Oncology Network (NASDAQ:AONC) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk, community ranking and earnings. Which has higher earnings and valuation, AONC or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmerican Oncology Network$1.34BN/AN/AN/AN/AAclarion$49.29KN/AN/AN/AN/A Is AONC or ACONW more profitable? Company Net Margins Return on Equity Return on Assets American Oncology NetworkN/A N/A N/A Aclarion N/A N/A N/A Does the MarketBeat Community favor AONC or ACONW? American Oncology Network and Aclarion both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAmerican Oncology NetworkN/AN/AAclarionN/AN/A Does the media prefer AONC or ACONW? In the previous week, American Oncology Network had 3 more articles in the media than Aclarion. MarketBeat recorded 3 mentions for American Oncology Network and 0 mentions for Aclarion. American Oncology Network's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score. Company Overall Sentiment American Oncology Network Neutral Aclarion Neutral SummaryAmerican Oncology Network beats Aclarion on 2 of the 2 factors compared between the two stocks. Ad InvestorPlaceWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.This market shakeup is going to be much more intense. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$196.58M$5.13B$9.07BDividend YieldN/A6.94%5.08%4.23%P/E RatioN/A540.3889.7417.18Price / SalesN/A285.021,116.12116.95Price / CashN/A47.1442.8237.86Price / BookN/A5.074.774.78Net IncomeN/A-$8.11M$120.15M$225.60M7 Day PerformanceN/A-0.95%-1.92%-1.23%1 Month PerformanceN/A6.21%11.47%3.36%1 Year PerformanceN/A11.55%30.52%16.60% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.03-1.2%N/A-36.1%$0.00$49,289.000.007Positive NewsAONCAmerican Oncology NetworkN/A$4.68+2.7%N/A-22.5%$0.00$1.34B0.001,520News CoverageDHACWDigital Health AcquisitionN/A$0.06flatN/AN/A$0.00N/A0.00N/ACORBFGlobal Cord BloodN/A$1.26flatN/A+15.4%$0.00$196.12M0.001,202High Trading VolumeLFMDPLifeMDN/A$22.500.0%N/A+17.1%$0.00$193.06M0.00230OTRKPOntrakN/A$0.28-3.5%N/A-57.6%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01flatN/AN/A$0.00$1.48B0.00500Positive NewsTALKWTalkspaceN/A$0.12-14.2%N/A+7.1%$0.00$181.29M0.00500Gap DownTOIIWOncology InstituteN/A$0.01flatN/A-95.0%$0.00$378.93M0.00660Positive NewsNTRANatera2.0775 of 5 stars$170.80+2.6%$152.67-10.6%+168.5%$22.55B$1.53B-97.053,293Positive NewsGap DownFMSFresenius Medical Care3.4964 of 5 stars$23.82+0.7%$24.30+2.0%+8.6%$13.98B$19.24B19.691,358News CoveragePositive News Related Companies and Tools Related Companies AONC Alternatives DHACW Alternatives CORBF Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives FMS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACONW) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.